“Tissue-Engineered ‘Metastases’: Treatment of Hepatic Colon Tumors With a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist ”. Journal of Cancer Research Updates, vol. 1, no. 1, Aug. 2021, pp. 69-77, https://doi.org/10.6000/1929-2279.2012.01.01.11.